Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05TMJ
|
|||
Former ID |
DNC006767
|
|||
Drug Name |
1-phenyl-3-(2-(pyridin-2-yl)quinazolin-4-yl)urea
|
|||
Synonyms |
CHEMBL423311; 1-phenyl-3-(2-(pyridin-2-yl)quinazolin-4-yl)urea; BDBM50088476; 1-[2-(2-Pyridyl)-4-quinazolinyl]-3-phenylurea
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H15N5O
|
|||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=N4
|
|||
InChI |
1S/C20H15N5O/c26-20(22-14-8-2-1-3-9-14)25-18-15-10-4-5-11-16(15)23-19(24-18)17-12-6-7-13-21-17/h1-13H,(H2,22,23,24,25,26)
|
|||
InChIKey |
XZUXPDFYRHJJLN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosine A3 receptor (ADORA3) | Target Info | Inhibitor | [1] |
Reactome | Adenosine P1 receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Nucleotide GPCRs | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models. J Med Chem. 2006 Jul 13;49(14):4085-97. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.